MCMelanie H. Chitwood

Melanie H. Chitwood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melanie H. Chitwood has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The global phylogeography of rapidly expanding multidrug resistant Ural lineage 4.2 Mycobacterium tuberculosis

    by Melanie H. Chitwood, Isabel Rancu, Yexuan Song, Barney I. Potter, Yi Ting Chew, Nelly Ciobanu, Valeriu Crudu, Caroline Colijn, Ted Cohen, Benjamin Sobkowiak

    Multidrug resistant tuberculosis (MDR-TB) epidemics are sustained by transmission of reproductively fit MDR M. tuberculosis ( Mtb ) strains. We search a large publicly available dataset of ~200,000 Mtb whole genome sequences to identify strains related to a highly successful MDR clade circulating in Moldova belonging to lineage 4.2.1/Ural. We characterize a clade of 1604 drug-resistant Mtb sequences harboring conserved resistance-conferring mutations. We identify the Russian Federation as the most likely country of origin for this clade and infer several independent migration events from Russia and Moldova to other European and Asian countries. We estimate that this clade is expanding more rapidly than comparable clades of lineage 4.2.1/Ural. The broad dispersal of this highly successful clade is an urgent global health threat. Genomic surveillance is essential to track the evolution and spread of this and other strains of concern.


  • National- and State-level SARS-CoV-2 Immunity Trends From January 2020 to December 2023: a Mathematical Modeling Analysis

    by Fayette Klaassen, Nicole A Swartwood, Melanie H Chitwood, Rafael Lopes, Masahiko Haraguchi, Joshua A Salomon, Ted Cohen, Nicolas A Menzies

    Background: Effective immune protection against SARS-CoV-2 infection and severe COVID-19 disease continues to change due to viral evolution and waning immunity. We estimated population-level immunity to SARS-CoV-2 for each of the 50 United States (U.S.) and the District of Columbia from January 2020 through December 2023. Methods: We updated a model of SARS-CoV-2 infections to align with the latest evidence on SARS-CoV-2 natural history and waning of immunity, and to integrate various data sources available throughout the pandemic. We used this model to produce population estimates of effective protection against SARS-CoV-2 infection and severe COVID-19 disease. Results: On 30 December 2023, 98.6% of the U.S. population had experienced immunological exposure to SARS-CoV-2 through infection and/or vaccination, with 88.3% (95% credible interval: 78.4%, 95.5%) having had at least one SARS-CoV-2 infection. Despite this high exposure, the average population-level protection against infection was 31.6% (25.1%, 41.2%). Population-level protection against severe disease was 66.1% (59.2%, 74.3%). Conclusion: A new wave of SARS-CoV-2 infections and COVID-19-associated hospitalizations began near the end of 2023, with the introduction of the JN.1 variant. This upturn suggests that the U.S. population remains at risk of SARS-CoV-2 infection and severe COVID-19 disease despite the high level of cumulative exposure in the United States. This decline in effective protection is likely due to both waning and continued viral evolution.


  • Quantifying disruptions to tuberculosis case detection in Brazilian states during the COVID-19 pandemic

    by Melanie H Chitwood, Nicolas A Menzies, Patricia Bartholomay, Daniele Maria Pelissari, José Nildo de Barros Silva Júnior, Luiza Ohana Harada, Fernanda Dockhorn Costa Johansen, Ethel Leonor Noia Maciel, Marcia C Castro, Mauro Sanchez, et al.

    Background: Globally, tuberculosis (TB) surveillance and care were severely impacted by the COVID-19 pandemic. In Brazil, TB notification rates decreased in the first 2 years of the pandemic. There is a need for rigorous model-based methods to quantify the impact of health system disruptions on TB control. In this study, we aimed to assess how the COVID-19 pandemic affected both incidence and case detection in Brazilian states. Methods: We used a Bayesian evidence synthesis model to estimate TB incidence and case detection rates over the period 2016–21 by using routinely collected case notification and mortality data. We then used a meta-regression framework to estimate factors associated with state-level rates of undiagnosed symptomatic TB. Results: We found that the probability that an individual with symptomatic TB was diagnosed decreased in the majority of states in April 2020 (median = –10.4%age points, interquartile range = –6.6, –16.2). Incident TB decreased slightly in April 2020 and rebounded beginning in 2021. Together, this led to an increase in missed TB cases in nearly every state during the pandemic. Nationally, we estimate that there were 20 671 (95% credible interval: 19 249, 22 501) missed TB cases between April 2020 and December 2021. Conclusion: Disruptions to the Brazilian healthcare system during the COVID-19 pandemic prevented tens of thousands of individuals with symptomatic disease from receiving a TB diagnosis. While some Brazilian states recovered rapidly to pre-pandemic levels of TB case detection, many did not and the rates of missed TB cases remained high through 2021.


  • Open Access

    Classification of unsequenced Mycobacterium tuberculosis strains in a high-burden setting using a pairwise logistic regression approach

    by Isabel Rancu, Benjamin Sobkowiak, Joshua L. Warren, Nelly Ciobanu, Alexandru Codreanu, Valeriu Crudu, Caroline Colijn, Ted Cohen, Melanie H. Chitwood

    Over the past three decades, molecular epidemiological studies have provided new opportunities to investigate the transmission dynamics of M. tuberculosis. In most studies, a sizable fraction of individuals with notified tuberculosis cannot be included, either because they do not have culture-positive disease (and thus do not have specimens available for molecular typing) or because resources for conducting sequencing are limited. A recent study introduced a regression-based approach for inferring the membership of unsequenced tuberculosis cases into transmission clusters based on host demographic and epidemiological data. This method was able to identify the most likely cluster to which an unsequenced strain belonged with an accuracy of 35%, though in a low burden setting where a large fraction of cases occurred among foreign-born migrants. Here, we apply a similar model to M. tuberculosis WGS data from the Republic of Moldova, a setting of relatively high local transmission. Using a maximum cluster span of ~40 SNPs and a cluster size cutoff of n ≥ 10, we could best predict the specific cluster to which each clustered case was most likely to be a member with an accuracy of 17.2%. In sensitivity analyses, we found that a more restrictive (~20 SNPs threshold) or permissive (~80 SNPs) threshold did not improve performance. We found that increasing the minimum cluster size improved prediction accuracy. These findings highlight the challenges of transmission interference in high burden settings like Moldova.

  • Open Access

    Distribution and transmission of M. tuberculosis in a high-HIV prevalence city in Malawi: A genomic and spatial analysis

    by Melanie H. Chitwood, Elizabeth L. Corbett, Victor Ndhlovu, Benjamin Sobkowiak, Caroline Colijn, Jason R. Andrews, Rachael M. Burke, Patrick G.T. Cudahy, Peter J. Dodd, Jeffrey W. Imai-Eaton, et al.

    Delays in identifying and treating individuals with infectious tuberculosis (TB) contribute to poor health outcomes and allow ongoing community transmission of M. tuberculosis (Mtb). Current recommendations for screening for tuberculosis specify community characteristics (e.g., areas with high local tuberculosis prevalence) that can be used to target screening within the general population. However, areas of higher tuberculosis burden are not necessarily areas with higher rates of transmission. We investigated the transmission of Mtb using high-resolution surveillance data in Blantyre, Malawi. We extracted and performed whole genome sequencing on mycobacterial DNA from cultured M. tuberculosis isolates obtained from culture-positive tuberculosis cases at the time of tuberculosis (TB) notification in Blantyre, Malawi between 2015-2019. We constructed putative transmission networks identified using TransPhylo and investigated individual and pair-wise demographic, clinical, and spatial factors associated with person-to-person transmission. We found that 56% of individuals with sequenced isolates had a probable transmission link to at least one other individual in the study. We identified thirteen putative transmission networks that included five or more individuals. Five of these networks had a single spatial focus of transmission in the city, and each focus centered in a distinct neighborhood in the city. We also found that approximately two-thirds of inferred transmission links occurred between individuals residing in different geographic zones of the city. While the majority of detected tuberculosis transmission events in Blantyre occurred between people living in different zones, there was evidence of distinct geographical concentration for five transmission networks. These findings suggest that targeted interventions in areas with evidence of localized transmission may be an effective local tactic, but will likely need to be augmented by city-wide interventions to improve case finding to have sustained impact.


  • Open Access

    Quantifying the spatiotemporal dynamics of the first two epidemic waves of SARS-CoV-2 infections in the United States

    by Rafael Lopes, Nicole A. Swartwood, Yu Lan, Melanie H. Chitwood, Fayette Klaassen, Joshua A. Salomon, Nicolas A. Menzies, Joshua L. Warren, Nathan D. Grubaugh, Ted Cohen

    SARS-CoV-2 infection rates displayed striking temporal and spatial variation during the emergence of new variants globally and within the United States. While spatiotemporal “waves” of infection have been observed, quantitative assessments of their spread remain limited. Here, we estimate and compare the speed and spatial extent of the first two major infection waves in the United States, illustrating these dynamics through detailed visualizations. Our findings reveal that the origins of these waves coincide with large gatherings and the relaxation of masking mandates. Notably, the second wave spread more rapidly than the first, driven by multiple, non-contiguous origins of infection. This highlights the role of regional heterogeneity in epidemic dynamics and underscores the importance of localized public health measures in mitigating ongoing outbreaks. Author Summary: Over the pandemic of SARS-CoV-2, efforts to identify and visualize the disease progression were made. However, quantitative visualization of the infections spreading are limited until today. Here we developed tools to visualize the spatial and temporal spreading of SARS-CoV-2 first two waves of infections over the Contiguous United States. We generated novels figures and movies that captures the dynamics of spreading and developed a new mapping of incidence of SARS-CoV-2 that goes below county-level. These outputs can help public health understanding and control efforts of the disease.

  • Open Access

    Classification of unsequenced Mycobacterium tuberculosis strains in a high-burden setting using a pairwise logistic regression approach

    by Isabel Rancu, Benjamin Sobkowiak, Joshua L. Warren, Nelly Ciobanu, Alexandru Codreanu, Valeriu Crudu, Caroline Colijn, Ted Cohen, Melanie H. Chitwood

    Over the past three decades, molecular epidemiological studies have provided new opportunities to investigate the transmission dynamics of M. tuberculosis. In most studies, a sizable fraction of individuals with notified tuberculosis cannot be included, either because they do not have culture-positive disease (and thus do not have specimens available for molecular typing) or because resources for conducting sequencing are limited. A recent study introduced a regression-based approach for inferring the membership of unsequenced tuberculosis cases into transmission clusters based on host demographic and epidemiological data. This method was able to identify the most likely cluster to which an unsequenced strain belonged with an accuracy of 35%, though in a low burden setting where a large fraction of cases occurred among foreign-born migrants. Here, we apply a similar model to M. tuberculosis WGS data from the Republic of Moldova, a setting of relatively high local transmission. Using a maximum cluster span of ~40 SNPs and a cluster size cutoff of n ≥ 10, we could best predict the specific cluster to which each clustered case was most likely to be a member with an accuracy of 17.2%. In sensitivity analyses, we found that a more restrictive (~20 SNPs threshold) or permissive (~80 SNPs) threshold did not improve performance. We found that increasing the minimum cluster size improved prediction accuracy. These findings highlight the challenges of transmission interference in high burden settings like Moldova.

  • Open Access

    Author Correction: The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova

    by Melanie H. Chitwood, Caroline Colijn, Chongguang Yang, Valeriu Crudu, Nelly Ciobanu, Alexandru Codreanu, Jaehee Kim, Isabel Rancu, Kyu Rhee, Ted Cohen, et al.


  • Open Access

    National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysis

    by Fayette Klaassen, Nicole A Swartwood, Melanie H Chitwood, Rafael Lopes, Masahiko Haraguchi, Joshua A Salomon, Ted Cohen, Nicolas A Menzies

    Introduction: Effective immune protection against SARS-CoV-2 infection and severe COVID-19 disease continues to change due to viral evolution and waning immunity. We estimated population-level immunity to SARS-CoV-2 for each of the fifty United States (U.S.) and the District of Columbia from January 2020 through December 2023. Methods: We updated a model of SARS-CoV-2 infections to align with the latest evidence on SARS-CoV-2 natural history and waning of immunity, and to integrate various data sources available throughout the pandemic. We used this model to produce population estimates of effective protection against SARS-CoV-2 infection and severe COVID-19 disease. Results: On December 30, 2023, 99.9% of the U.S. population had experienced immunological exposure to SARS-CoV-2 through infection and/or vaccination, with 99.4% (95% credible interval (CrI): 92.4-100%) having had at least one SARS-CoV-2 infection. Despite this high exposure, the average population-level protection against infection was 53.6% (95% CrI: 38.7-71.5%). Population-level protection against severe disease was 82.6% (95% CrI: 71.5-91.7%). Discussion: A new wave of SARS-CoV-2 infections and COVID-19-associated hospitalizations began near the end of 2023, with the introduction of the JN.1 variant. This upturn suggests that the U.S. population remains at risk of SARS-CoV-2 infection and severe COVID-19 disease despite the high level of cumulative exposure in the United States. This decline in effective protection is likely due to both waning and continued viral evolution.


  • Open Access

    e3SIM: epidemiological-ecological-evolutionary simulation framework for genomic epidemiology

    by Peiyu Xu, Shenni Liang, Andrew Hahn, Vivian Zhao, Wai Tung 'JAck' Lo, Benjamin C. Haller, Benjamin Sobkowiak, Melanie H. Chitwood, Caroline Colijn, Ted Cohen, et al.

    Infectious disease dynamics are driven by the complex interplay of epidemiological, ecological, and evolutionary processes. Accurately modeling these interactions is crucial for understanding pathogen spread and informing public health strategies. However, existing simulators often fail to capture the dynamic interplay between these processes, resulting in oversimplified models that do not fully reflect real-world complexities in which the pathogen’s genetic evolution dynamically influences disease transmission. We introduce the epidemiological-ecological-evolutionary simulator (e3SIM), an open-source framework that concurrently models the transmission dynamics and molecular evolution of pathogens within a host population while integrating environmental factors. Using an agent-based, discrete-generation, forward-in-time approach, e3SIM incorporates compartmental models, host-population contact networks, and quantitative-trait models for pathogens. This integration allows for realistic simulations of disease spread and pathogen evolution. Key features include a modular and scalable design, flexibility in modeling various epidemiological and population-genetic complexities, incorporation of time-varying environmental factors, and a user-friendly graphical interface. We demonstrate e3SIM’s capabilities through simulations of realistic outbreak scenarios with SARS-CoV-2 and Mycobacterium tuberculosis, illustrating its flexibility for studying the genomic epidemiology of diverse pathogen types.